abstract |
The invention provides a pharmaceutical composition and kit for treating certain neurologic and psychiatric disorders in mammals, including humans, comprising a selective PDE10 inhibitor. In particular, the invention relates to treatment of mood, movement, and anxiety disorders; psychosis; drug, for example alcohol, addiction; and disorders having as a symptom deficient cognition. The invention furthermore provides the use of papaverine as a selective inhibitor of PDE10. |